Abhijeet Akella

First of all, on the Specialty Chemicals business, would it be possible to just share the revenue growth that we've seen in the first 9 months of the year?

Okay, thank you. The other thing was on the Chemical segment margins. There seems to be some quarter-on-quarter moderation sequentially, about 170-180 basis points. So what might be the reason for that? Is it primarily coming from specialty chems or something else? Could it be a tariff impact from R32?

Okay. As far as R32 is concerned in terms of sharing the tariff impact with customers and any sort of broad outline of how discussions are shaping up?